EDAP TMS S.A Market Cap ($132.10 Million)
Market Cap & Net Worth: EDAP TMS S.A (EDA)
EDAP TMS S.A market cap. EDAP TMS S.A (F:EDA) has a market capitalization of $132.10 Million (€112.99 Million) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #18028 globally and #1681 in its home market, demonstrating a 4.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EDAP TMS S.A's stock price €3.70 by its total outstanding shares 37527950 (37.53 Million).
EDAP TMS S.A Market Cap History (2015–2026)
EDAP TMS S.A market cap history from 2015 to 2026. Data shows change from $173.04 Million to $162.33 Million (-0.42% CAGR). Check today's stock price for EDAP TMS S.A for real-time trading data and today's change.
EDAP TMS S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EDAP TMS S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see EDAP TMS S.A operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
1.68x
EDAP TMS S.A's market cap is 1.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $133.60 Million | $35.61 Million | $3.84 Million | 3.75x | 34.77x |
| 2017 | $96.52 Million | $35.75 Million | -$681.00K | 2.70x | N/A |
| 2018 | $61.86 Million | $39.18 Million | -$338.00K | 1.58x | N/A |
| 2019 | $164.97 Million | $44.91 Million | $1.51 Million | 3.67x | 109.10x |
| 2020 | $173.74 Million | $47.80 Million | -$1.96 Million | 3.63x | N/A |
| 2021 | $201.82 Million | $44.07 Million | $700.00K | 4.58x | 288.32x |
| 2022 | $447.52 Million | $55.11 Million | -$2.93 Million | 8.12x | N/A |
| 2023 | $204.45 Million | $66.79 Million | -$23.41 Million | 3.06x | N/A |
| 2024 | $89.50 Million | $69.40 Million | -$20.58 Million | 1.29x | N/A |
| 2025 | $118.46 Million | $70.53 Million | -$29.25 Million | 1.68x | N/A |
Competitor Companies of EDA by Market Capitalization
Companies near EDAP TMS S.A in the global market cap rankings as of October 31, 2026. See EDA net asset quality score to understand what proportion of total assets are financed by equity.
Key companies related to EDAP TMS S.A by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #631 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1162 globally with a market cap of $22.22 Billion USD ( AU$31.40 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $980.88 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.53 |
| #631 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $251.09 |
| #1162 | Sigma Healthcare Ltd | AU:SIG | $22.22 Billion | AU$2.72 |
Market Capitalization of EDAP TMS S.A (2015–2026)
Market capitalization of EDAP TMS S.A from 2015 to today. Between 2015 and today, EDAP TMS S.A's market cap moved from $173.04 Million to $ 162.33 Million, with a yearly change of -0.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €162.33 Million | +37.04% |
| 2025 | €118.46 Million | +32.35% |
| 2024 | €89.50 Million | -56.22% |
| 2023 | €204.45 Million | -54.31% |
| 2022 | €447.52 Million | +121.74% |
| 2021 | €201.82 Million | +16.16% |
| 2020 | €173.74 Million | +5.32% |
| 2019 | €164.97 Million | +166.67% |
| 2018 | €61.86 Million | -35.91% |
| 2017 | €96.52 Million | -27.75% |
| 2016 | €133.60 Million | -22.79% |
| 2015 | €173.04 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of EDAP TMS S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $132.10 Million USD |
| MoneyControl | $132.10 Million USD |
| MarketWatch | $132.10 Million USD |
| marketcap.company | $132.10 Million USD |
| Reuters | $132.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EDAP TMS S.A
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more